Skip to main content
. 2023 Jun 21;18(4):571–583. doi: 10.1007/s11523-023-00973-7

Fig. 4.

Fig. 4

Forest plots of Cox proportional hazard models for mAEFS, rwPFS, and OS. Effects of alectinib versus crizotinib as the first ALK TKI treatment in a major-adverse-event-free survival, b real-world progression-free survival, and c overall survivals were estimated using multivariable Cox proportional hazard regression models. Abbreviations: mAEFS: major-adverse-event-free survival, rwPFS: real-world progression-free survival, OS: overall survival